(Q53265601)

12 May 2018

title

Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model. (English)

1 reference

12 May 2018

1 reference

7

Otto C Boerman

1 reference

12 May 2018

3

Wim J G Oyen

0 references

Johan Bussink

6

object named as

Johan Bussink

1 reference

12 May 2018

author name string

Bianca A W Hoeben

1

1 reference

12 May 2018

Janneke D M Molkenboer-Kuenen

2

1 reference

12 May 2018

Wim J G Oyen

3

1 reference

12 May 2018

Wenny J M Peeters

4

1 reference

12 May 2018

Johannes H A M Kaanders

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 December 2010

1 reference

12 May 2018

International Journal of Cancer

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 May 2018

volume

129

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

870-878

1 reference

12 May 2018

Review of epidermal growth factor receptor biology

cites work

1 reference

Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy

21 January 2018

1 reference

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

21 January 2018

1 reference

EGFR and cancer prognosis

21 January 2018

1 reference

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation

21 January 2018

1 reference

Systemic therapy for colorectal cancer

21 January 2018

1 reference

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

PET-CT for response assessment and treatment adaptation in head and neck cancer

21 January 2018

1 reference

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

21 January 2018

1 reference

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

21 January 2018

1 reference

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

21 January 2018

1 reference

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

21 January 2018

1 reference

Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications

21 January 2018

1 reference

In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies

21 January 2018

1 reference

PET of EGFR antibody distribution in head and neck squamous cell carcinoma models

21 January 2018

1 reference

Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma

21 January 2018

1 reference

Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.

21 January 2018

1 reference

ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model

21 January 2018

1 reference

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

21 January 2018

1 reference

Fates of endocytosed somatostatin sst2 receptors and associated agonists

21 January 2018

1 reference

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

A pyramid approach to subpixel registration based on intensity

21 January 2018

1 reference

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.

21 January 2018

1 reference

U-SPECT-II: An Ultra-High-Resolution Device for Molecular Small-Animal Imaging

21 January 2018

1 reference

Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines

21 January 2018

1 reference

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer

21 January 2018

1 reference

Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF.

21 January 2018

1 reference

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII.

21 January 2018

1 reference

A phase I study of 99mTc-hR3 (DiaCIM), a humanized immunoconjugate directed towards the epidermal growth factor receptor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25727

1 reference

12 May 2018

1 reference

12 May 2018